GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (HKSE:02190) » Definitions » Gross Margin %

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Gross Margin % : 72.02% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Zylox-Tonbridge Medical Technology Co's Gross Profit for the six months ended in Dec. 2023 was HK$234.4 Mil. Zylox-Tonbridge Medical Technology Co's Revenue for the six months ended in Dec. 2023 was HK$325.5 Mil. Therefore, Zylox-Tonbridge Medical Technology Co's Gross Margin % for the quarter that ended in Dec. 2023 was 72.02%.


The historical rank and industry rank for Zylox-Tonbridge Medical Technology Co's Gross Margin % or its related term are showing as below:

HKSE:02190' s Gross Margin % Range Over the Past 10 Years
Min: 24.24   Med: 72.95   Max: 75.63
Current: 72.95


During the past 5 years, the highest Gross Margin % of Zylox-Tonbridge Medical Technology Co was 75.63%. The lowest was 24.24%. And the median was 72.95%.

HKSE:02190's Gross Margin % is ranked better than
80.87% of 800 companies
in the Medical Devices & Instruments industry
Industry Median: 53.295 vs HKSE:02190: 72.95

Zylox-Tonbridge Medical Technology Co had a gross margin of 72.02% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Zylox-Tonbridge Medical Technology Co was 0.00% per year.


Zylox-Tonbridge Medical Technology Co Gross Margin % Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co Gross Margin % Chart

Zylox-Tonbridge Medical Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
24.24 58.94 74.13 75.63 72.95

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only 74.94 75.60 75.65 74.15 72.02

Competitive Comparison of Zylox-Tonbridge Medical Technology Co's Gross Margin %

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zylox-Tonbridge Medical Technology Co's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's Gross Margin % falls into.



Zylox-Tonbridge Medical Technology Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Zylox-Tonbridge Medical Technology Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=421.1 / 577.246
=(Revenue - Cost of Goods Sold) / Revenue
=(577.246 - 156.154) / 577.246
=72.95 %

Zylox-Tonbridge Medical Technology Co's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=234.4 / 325.534
=(Revenue - Cost of Goods Sold) / Revenue
=(325.534 - 91.091) / 325.534
=72.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Zylox-Tonbridge Medical Technology Co  (HKSE:02190) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Zylox-Tonbridge Medical Technology Co had a gross margin of 72.02% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Zylox-Tonbridge Medical Technology Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zylox-Tonbridge Medical Technology Co (HKSE:02190) Business Description

Traded in Other Exchanges
N/A
Address
No. 18 Keji Avenue, Yuhang Street, 1st & 2nd Floors, Building 1, Yuhang District, Zhejiang Province, Hangzhou, CHN
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries.

Zylox-Tonbridge Medical Technology Co (HKSE:02190) Headlines

No Headlines